Laboratorio Farmaceutico SIT Expands Portfolio with Mizollen Acquisition

Deal News | Jul 03, 2025 | Legal Community Italy

Laboratorio Farmaceutico SIT Expands Portfolio with Mizollen Acquisition

Laboratorio Farmaceutico SIT has acquired the pharmaceutical product Mizollen, an important antihistamine used for treating allergic rhinitis and hives. This acquisition will allow SIT to enhance and expand its product portfolio, significantly strengthen its presence in the French market, and establish itself as a reliable partner for international brand drug acquisitions. SIT continues its journey of innovation and development, aiming to meet the needs of patients and healthcare operators with high-quality solutions. Legal proceedings and structuring were comprehensively managed by De Berti Jacchia's team, led by partner Pietro Meda, with extensive support from partners and senior associates across various departments, including M&A, intellectual property, and banking aspects.

Sectors

  • Pharmaceuticals
  • Legal Advisory

Geography

  • Italy – Laboratorio Farmaceutico SIT and the law firm De Berti Jacchia are based in Italy.
  • France – The acquisition of Mizollen enhances SIT's market presence in France.

Industry

  • Pharmaceuticals – The article revolves around Laboratorio Farmaceutico SIT's acquisition of Mizollen, a significant pharmaceutical product.
  • Legal Advisory – De Berti Jacchia provided comprehensive legal advisory services for the acquisition, covering M&A, intellectual property, and banking aspects.

Financials

    Participants

    NameRoleTypeDescription
    Laboratorio Farmaceutico SITBuyerCompanyAn Italian pharmaceutical company expanding its product portfolio and market presence.
    De Berti JacchiaLegal AdvisorCompanyItalian law firm providing legal advisory services for the acquisition.
    Pietro MedaLead PartnerPeoplePartner at De Berti Jacchia, leading the legal team in the acquisition.
    Claudio Corba ColomboPartnerPeoplePartner at De Berti Jacchia M&A department, co-managing the transaction.
    Andrea TerragniIntellectual Property PartnerPeoplePartner at De Berti Jacchia focusing on intellectual property aspects.
    Giuseppe CristianoBanking PartnerPeoplePartner at De Berti Jacchia handling banking aspects of the acquisition.